Anika Therapeutics (ANIK) Profit After Tax (2010 - 2026)
Anika Therapeutics (ANIK) reported Profit After Tax of -$5.1 million for Q1 2026, down 27.74% year-over-year from -$7.0 million in Q1 2025, and down 661.78% quarter-over-quarter from $900000.0 in Q4 2025.
Anika Therapeutics (ANIK) Profit After Tax (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has 17 years of Profit After Tax data on file, last reported at -$5.1 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$5.1 million, down 27.74% year-over-year; the trailing twelve-month figure through Mar 2026 was -$11.3 million (up 69.0% YoY), and the FY2025 annual result was -$10.9 million, down 23.24% from the prior year.
- Profit After Tax fell to -$5.1 million in Q1 2026 per ANIK's latest filing, from $900000.0 in the prior quarter.
- Over five years, Profit After Tax peaked at $16.2 million in Q4 2023 and troughed at -$29.9 million in Q3 2024.
- A 5-year average of -$4.2 million and a median of -$4.0 million in 2025 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2023 and 2025: Profit After Tax jumped 430.64% in 2023, then sank 4411.36% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$4.9 million in 2022, then jumped by 430.64% to $16.2 million in 2023, then slumped by 115.32% to -$2.5 million in 2024, then jumped by 136.2% to $900000.0 in 2025, then plunged by 661.78% to -$5.1 million in 2026.
- Business Quant data shows ANIK's Profit After Tax at -$5.1 million in Q1 2026, $900000.0 in Q4 2025, and -$3.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 369.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -1.36 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 16.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Anika Therapeutics | 197.89 Mn | 131.10 Mn | 19.00 Mn | -5.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.06 Mn |
| Dec 31, 2025 | 900,000.00 |
| Sep 30, 2025 | -3.18 Mn |
| Jun 30, 2025 | -3.97 Mn |
| Mar 31, 2025 | -3.96 Mn |
| Dec 31, 2024 | -2.49 Mn |
| Sep 30, 2024 | -29.92 Mn |
| Jun 30, 2024 | -88,000.00 |
| Mar 31, 2024 | -4.51 Mn |
| Dec 31, 2023 | 16.23 Mn |
| Sep 30, 2023 | -6.58 Mn |
| Jun 30, 2023 | -2.74 Mn |
| Mar 31, 2023 | -10.35 Mn |
| Dec 31, 2022 | -4.91 Mn |
| Sep 30, 2022 | -4.18 Mn |
| Jun 30, 2022 | -2.84 Mn |
| Mar 31, 2022 | -2.93 Mn |
| Dec 31, 2021 | -5.79 Mn |
| Sep 30, 2021 | 558,000.00 |
| Jun 30, 2021 | 6.53 Mn |